Stem, Inc. (NYSE:STEM) Shares Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. decreased its holdings in shares of Stem, Inc. (NYSE:STEMFree Report) by 22.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 106,156 shares of the company’s stock after selling 30,339 shares during the quarter. Oppenheimer & Co. Inc. owned approximately 0.07% of Stem worth $37,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Personalized Indexing Management LLC purchased a new stake in Stem during the second quarter worth approximately $30,000. Nisa Investment Advisors LLC lifted its stake in Stem by 2,416.1% during the second quarter. Nisa Investment Advisors LLC now owns 28,507 shares of the company’s stock worth $32,000 after purchasing an additional 27,374 shares during the last quarter. SG Americas Securities LLC lifted its stake in Stem by 73.9% during the second quarter. SG Americas Securities LLC now owns 33,666 shares of the company’s stock worth $37,000 after purchasing an additional 14,307 shares during the last quarter. Cetera Advisors LLC purchased a new stake in Stem during the first quarter worth approximately $179,000. Finally, Tidal Investments LLC lifted its stake in Stem by 904.0% during the first quarter. Tidal Investments LLC now owns 121,741 shares of the company’s stock worth $267,000 after purchasing an additional 109,616 shares during the last quarter. Hedge funds and other institutional investors own 61.63% of the company’s stock.

Stem Price Performance

Stem stock opened at $0.39 on Friday. Stem, Inc. has a 12 month low of $0.30 and a 12 month high of $4.30. The company has a debt-to-equity ratio of 1.41, a current ratio of 1.10 and a quick ratio of 0.94. The business has a 50 day simple moving average of $0.43 and a 200-day simple moving average of $0.82. The stock has a market capitalization of $63.77 million, a PE ratio of -0.08 and a beta of 1.65.

Analysts Set New Price Targets

Several research firms recently weighed in on STEM. Evercore ISI decreased their target price on Stem from $9.00 to $5.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Piper Sandler reduced their price objective on Stem from $1.50 to $0.30 and set a “neutral” rating for the company in a research note on Friday. The Goldman Sachs Group reduced their price objective on Stem from $0.75 to $0.65 and set a “neutral” rating for the company in a research note on Friday, November 1st. Susquehanna boosted their price objective on Stem from $0.50 to $0.60 and gave the company a “neutral” rating in a research note on Wednesday, October 16th. Finally, Barclays reduced their price objective on Stem from $4.00 to $1.00 and set an “equal weight” rating for the company in a research note on Friday, October 18th. Seven analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Stem presently has an average rating of “Hold” and an average price target of $1.67.

View Our Latest Analysis on STEM

Stem Profile

(Free Report)

Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.

Recommended Stories

Want to see what other hedge funds are holding STEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stem, Inc. (NYSE:STEMFree Report).

Institutional Ownership by Quarter for Stem (NYSE:STEM)

Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.